Interactions between Xenobiotics and DME (XEOTIC)
|
Health or Environmental Toxicant(s) |
Biotoxin |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Cylindrospermopsin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00905
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Cyanotoxin |
DME Modulation |
Cylindrospermopsin up-regulates the expression of DME ALDH1A2 |
[1] |
Natural Product(s), Extract(s) or Medicine(s) |
Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Benzaldehydes |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00996
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Natural Product |
DME Modulation |
Benzaldehydes inhibits the drug-metabolizing activity of DME ALDH1A2 |
[2] |
Tunicamycin A |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01494
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Product |
DME Modulation |
Tunicamycin A inhibits the expression of DME ALDH1A2 |
[3] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 5 Xenobiotics
|
Disulfiram |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00028
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Disulfiram inhibits the drug-metabolizing activity of DME ALDH1A2 |
[2] |
Doxorubicin hydrochloride |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00292
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Doxorubicin hydrochloride inhibits the expression of DME ALDH1A2 |
[4] |
Methamphetamine |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00108
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Methamphetamine up-regulates the expression of DME ALDH1A2 |
[5] |
Rosiglitazone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00380
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Rosiglitazone induces the drug-metabolizing activity of DME ALDH1A2 |
[6] |
Valproic acid |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00029
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Valproic acid up-regulates the expression of DME ALDH1A2 |
[7] |
Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
MS-275 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00581
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
MS-275 inhibits the expression of DME ALDH1A2 |
[8] |
Drug in Phase 1 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Sodium arsenite |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00632
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
Sodium arsenite inhibits the expression of DME ALDH1A2 |
[9] |
|
|
|
|
|
|